Arjuna Capital
Source: SEC Form 13F · as of Mar 2026Arjuna Capital holds 12 biotech & pharma companies tracked by BioSniper, totaling $32.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$32.5M
| Company | Shares | Value |
|---|---|---|
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 123,202 | $6.8M |
| MCKMcKesson Corporation | 5,478 | $4.7M |
| LLYELI LILLY & Co | 4,486 | $4.1M |
| NVSNovartis AG | 27,009 | $4.1M |
| AMGNAMGEN INC | 7,889 | $2.8M |
| SNYSanofi | 57,028 | $2.7M |
| CAHCardinal Health Inc. | 10,270 | $2.2M |
| DGXQuest Diagnostics Incorporated | 8,329 | $1.6M |
| CORCencora Inc. | 4,825 | $1.5M |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 62,195 | $1.2M |
| UTHRUNITED THERAPEUTICS Corp | 662 | $393K |
| REGNREGENERON PHARMACEUTICALS, INC. | 457 | $353K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.